The global Small Molecule Anti-tumor Targted Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Small Molecule Anti-tumor Targted Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Small Molecule Anti-tumor Targted Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Molecule Anti-tumor Targted Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Small Molecule Anti-tumor Targted Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Molecule Anti-tumor Targted Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Molecule Anti-tumor Targted Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Small Molecule Anti-tumor Targted Drug Market Report

Report Metric	Details
Report Name	Small Molecule Anti-tumor Targted Drug Market
CAGR	5%
Segment by Type	EGFR ALK Bcr-Abl Others
Segment by Application	Liver Cancer Colorectal Cancer Lung Cancer Gastric Cancer Breast Cancer Esophageal Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Small Molecule Anti-tumor Targted Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Anti-tumor Targted Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Molecule Anti-tumor Targted Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Small Molecule Anti-tumor Targted Drug Market report?

Ans: The main players in the Small Molecule Anti-tumor Targted Drug Market are Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma

What are the Application segmentation covered in the Small Molecule Anti-tumor Targted Drug Market report?

Ans: The Applications covered in the Small Molecule Anti-tumor Targted Drug Market report are Liver Cancer, Colorectal Cancer, Lung Cancer, Gastric Cancer, Breast Cancer, Esophageal Cancer, Others

What are the Type segmentation covered in the Small Molecule Anti-tumor Targted Drug Market report?

Ans: The Types covered in the Small Molecule Anti-tumor Targted Drug Market report are EGFR, ALK, Bcr-Abl, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 EGFR

1.2.3 ALK

1.2.4 Bcr-Abl

1.2.5 Others

1.3 Market by Application

1.3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Liver Cancer

1.3.3 Colorectal Cancer

1.3.4 Lung Cancer

1.3.5 Gastric Cancer

1.3.6 Breast Cancer

1.3.7 Esophageal Cancer

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule Anti-tumor Targted Drug Market Perspective (2019-2030)

2.2 Global Small Molecule Anti-tumor Targted Drug Growth Trends by Region

2.2.1 Small Molecule Anti-tumor Targted Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Small Molecule Anti-tumor Targted Drug Historic Market Size by Region (2019-2024)

2.2.3 Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2025-2030)

2.3 Small Molecule Anti-tumor Targted Drug Market Dynamics

2.3.1 Small Molecule Anti-tumor Targted Drug Industry Trends

2.3.2 Small Molecule Anti-tumor Targted Drug Market Drivers

2.3.3 Small Molecule Anti-tumor Targted Drug Market Challenges

2.3.4 Small Molecule Anti-tumor Targted Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Small Molecule Anti-tumor Targted Drug by Players

3.1.1 Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2019-2024)

3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2019-2024)

3.2 Global Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Small Molecule Anti-tumor Targted Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio

3.4.1 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Anti-tumor Targted Drug Revenue in 2023

3.5 Global Key Players of Small Molecule Anti-tumor Targted Drug Head office and Area Served

3.6 Global Key Players of Small Molecule Anti-tumor Targted Drug, Product and Application

3.7 Global Key Players of Small Molecule Anti-tumor Targted Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Anti-tumor Targted Drug Breakdown Data by Type

4.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2019-2024)

4.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2025-2030)

5 Small Molecule Anti-tumor Targted Drug Breakdown Data by Application

5.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2019-2024)

5.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2019-2030)

6.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type

6.2.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024)

6.2.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030)

6.2.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application

6.3.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024)

6.3.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030)

6.3.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

6.4 North America Small Molecule Anti-tumor Targted Drug Market Size by Country

6.4.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024)

6.4.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size (2019-2030)

7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type

7.2.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024)

7.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030)

7.2.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application

7.3.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024)

7.3.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030)

7.3.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

7.4 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country

7.4.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024)

7.4.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Small Molecule Anti-tumor Targted Drug Market Size (2019-2030)

8.2 China Small Molecule Anti-tumor Targted Drug Market Size by Type

8.2.1 China Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024)

8.2.2 China Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030)

8.2.3 China Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

8.3 China Small Molecule Anti-tumor Targted Drug Market Size by Application

8.3.1 China Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024)

8.3.2 China Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030)

8.3.3 China Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Small Molecule Anti-tumor Targted Drug Market Size (2019-2030)

9.2 Asia Small Molecule Anti-tumor Targted Drug Market Size by Type

9.2.1 Asia Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024)

9.2.2 Asia Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030)

9.2.3 Asia Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

9.3 Asia Small Molecule Anti-tumor Targted Drug Market Size by Application

9.3.1 Asia Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024)

9.3.2 Asia Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030)

9.3.3 Asia Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

9.4 Asia Small Molecule Anti-tumor Targted Drug Market Size by Region

9.4.1 Asia Small Molecule Anti-tumor Targted Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Small Molecule Anti-tumor Targted Drug Market Size by Region (2019-2024)

9.4.3 Asia Small Molecule Anti-tumor Targted Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Astrazeneca

11.1.1 Astrazeneca Company Details

11.1.2 Astrazeneca Business Overview

11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Introduction

11.1.4 Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.1.5 Astrazeneca Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Introduction

11.2.4 Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Millennium Pharmaceuticals

11.3.1 Millennium Pharmaceuticals Company Details

11.3.2 Millennium Pharmaceuticals Business Overview

11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Introduction

11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.3.5 Millennium Pharmaceuticals Recent Developments

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Introduction

11.4.4 Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.4.5 Bayer Recent Developments

11.5 Exelixis

11.5.1 Exelixis Company Details

11.5.2 Exelixis Business Overview

11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Introduction

11.5.4 Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.5.5 Exelixis Recent Developments

11.6 Abbvie

11.6.1 Abbvie Company Details

11.6.2 Abbvie Business Overview

11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Introduction

11.6.4 Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.6.5 Abbvie Recent Developments

11.7 Boehringer-Ingelheim

11.7.1 Boehringer-Ingelheim Company Details

11.7.2 Boehringer-Ingelheim Business Overview

11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Introduction

11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.7.5 Boehringer-Ingelheim Recent Developments

11.8 Eisai

11.8.1 Eisai Company Details

11.8.2 Eisai Business Overview

11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Introduction

11.8.4 Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.8.5 Eisai Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Introduction

11.9.4 Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.9.5 Pfizer Recent Developments

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Details

11.10.2 Bristol-Myers Squibb Business Overview

11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Introduction

11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.10.5 Bristol-Myers Squibb Recent Developments

11.11 Roche

11.11.1 Roche Company Details

11.11.2 Roche Business Overview

11.11.3 Roche Small Molecule Anti-tumor Targted Drug Introduction

11.11.4 Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.11.5 Roche Recent Developments

11.12 Bettapharma

11.12.1 Bettapharma Company Details

11.12.2 Bettapharma Business Overview

11.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Introduction

11.12.4 Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

11.12.5 Bettapharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Novartis

Millennium Pharmaceuticals

List of Tables

Table 1. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of EGFR

Table 3. Key Players of ALK

Table 4. Key Players of Bcr-Abl

Table 5. Key Players of Others

Table 6. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2019-2024)

Table 10. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2025-2030)

Table 12. Small Molecule Anti-tumor Targted Drug Market Trends

Table 13. Small Molecule Anti-tumor Targted Drug Market Drivers

Table 14. Small Molecule Anti-tumor Targted Drug Market Challenges

Table 15. Small Molecule Anti-tumor Targted Drug Market Restraints

Table 16. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Players (2019-2024)

Table 18. Global Top Small Molecule Anti-tumor Targted Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2023)

Table 19. Global Small Molecule Anti-tumor Targted Drug Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Small Molecule Anti-tumor Targted Drug, Headquarters and Area Served

Table 22. Global Key Players of Small Molecule Anti-tumor Targted Drug, Product and Application

Table 23. Global Key Players of Small Molecule Anti-tumor Targted Drug, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2019-2024)

Table 27. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2025-2030)

Table 29. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2019-2024)

Table 31. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2025-2030)

Table 33. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Small Molecule Anti-tumor Targted Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Small Molecule Anti-tumor Targted Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Small Molecule Anti-tumor Targted Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Small Molecule Anti-tumor Targted Drug Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Small Molecule Anti-tumor Targted Drug Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2025-2030) & (US$ Million)

Table 65. Astrazeneca Company Details

Table 66. Astrazeneca Business Overview

Table 67. Astrazeneca Small Molecule Anti-tumor Targted Drug Product

Table 68. Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 69. Astrazeneca Recent Developments

Table 70. Novartis Company Details

Table 71. Novartis Business Overview

Table 72. Novartis Small Molecule Anti-tumor Targted Drug Product

Table 73. Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 74. Novartis Recent Developments

Table 75. Millennium Pharmaceuticals Company Details

Table 76. Millennium Pharmaceuticals Business Overview

Table 77. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product

Table 78. Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 79. Millennium Pharmaceuticals Recent Developments

Table 80. Bayer Company Details

Table 81. Bayer Business Overview

Table 82. Bayer Small Molecule Anti-tumor Targted Drug Product

Table 83. Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 84. Bayer Recent Developments

Table 85. Exelixis Company Details

Table 86. Exelixis Business Overview

Table 87. Exelixis Small Molecule Anti-tumor Targted Drug Product

Table 88. Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 89. Exelixis Recent Developments

Table 90. Abbvie Company Details

Table 91. Abbvie Business Overview

Table 92. Abbvie Small Molecule Anti-tumor Targted Drug Product

Table 93. Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 94. Abbvie Recent Developments

Table 95. Boehringer-Ingelheim Company Details

Table 96. Boehringer-Ingelheim Business Overview

Table 97. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product

Table 98. Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 99. Boehringer-Ingelheim Recent Developments

Table 100. Eisai Company Details

Table 101. Eisai Business Overview

Table 102. Eisai Small Molecule Anti-tumor Targted Drug Product

Table 103. Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 104. Eisai Recent Developments

Table 105. Pfizer Company Details

Table 106. Pfizer Business Overview

Table 107. Pfizer Small Molecule Anti-tumor Targted Drug Product

Table 108. Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 109. Pfizer Recent Developments

Table 110. Bristol-Myers Squibb Company Details

Table 111. Bristol-Myers Squibb Business Overview

Table 112. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product

Table 113. Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 114. Bristol-Myers Squibb Recent Developments

Table 115. Roche Company Details

Table 116. Roche Business Overview

Table 117. Roche Small Molecule Anti-tumor Targted Drug Product

Table 118. Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 119. Roche Recent Developments

Table 120. Bettapharma Company Details

Table 121. Bettapharma Business Overview

Table 122. Bettapharma Small Molecule Anti-tumor Targted Drug Product

Table 123. Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2019-2024) & (US$ Million)

Table 124. Bettapharma Recent Developments

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Small Molecule Anti-tumor Targted Drug Market Share by Type: 2023 VS 2030

Figure 3. EGFR Features

Figure 4. ALK Features

Figure 5. Bcr-Abl Features

Figure 6. Others Features

Figure 7. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2023 VS 2030

Figure 9. Liver Cancer Case Studies

Figure 10. Colorectal Cancer Case Studies

Figure 11. Lung Cancer Case Studies

Figure 12. Gastric Cancer Case Studies

Figure 13. Breast Cancer Case Studies

Figure 14. Esophageal Cancer Case Studies

Figure 15. Others Case Studies

Figure 16. Small Molecule Anti-tumor Targted Drug Report Years Considered

Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Small Molecule Anti-tumor Targted Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Small Molecule Anti-tumor Targted Drug Market Share by Region: 2023 VS 2030

Figure 20. Global Small Molecule Anti-tumor Targted Drug Market Share by Players in 2023

Figure 21. Global Top Small Molecule Anti-tumor Targted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2023

Figure 23. North America Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

Figure 25. North America Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

Figure 26. North America Small Molecule Anti-tumor Targted Drug Market Share by Country (2019-2030)

Figure 27. United States Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Small Molecule Anti-tumor Targted Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 30. Europe Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

Figure 31. Europe Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

Figure 32. Europe Small Molecule Anti-tumor Targted Drug Market Share by Country (2019-2030)

Figure 33. Germany Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. China Small Molecule Anti-tumor Targted Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 40. China Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

Figure 41. China Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

Figure 42. Asia Small Molecule Anti-tumor Targted Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 43. Asia Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

Figure 44. Asia Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

Figure 45. Asia Small Molecule Anti-tumor Targted Drug Market Share by Region (2019-2030)

Figure 46. Japan Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. South Korea Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. China Taiwan Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. India Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Australia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Share by Type (2019-2030)

Figure 54. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2030)

Figure 55. Middle East, Africa, and Latin America Small Molecule Anti-tumor Targted Drug Market Share by Country (2019-2030)

Figure 56. Brazil Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Mexico Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Turkey Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Israel Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. Astrazeneca Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 63. Novartis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 64. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 66. Exelixis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 67. Abbvie Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 68. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 69. Eisai Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 70. Pfizer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 72. Roche Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 73. Bettapharma Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions